Document is current

Any future updates will be listed below

First-line benmelstobart plus anlotinib and chemotherapy in advanced or metastatic/recurrent esophageal squamous cell carcinoma: a multi-center phase 2 study

Crossref DOI link: https://doi.org/10.1038/s41392-024-02008-7

Published Online: 2024-11-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark